Attack-related severity: A key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders

Journal of the Neurological Sciences

Volumn 225, Issue 1-2, 2004, Pages 71-78

  Fukazawa, Toshiyuki ^a   Kikuchi, Seiji ^b   Niino, Masaaki ^b   Yabe, Ichiro ^b   Miyagishi, Ryuji ^b   Fukaura, Hikoaki ^b   Hamada, Takeshi ^a   Tashiro, Kunio ^c   Sasaki, Hidenao ^b  

^a Hokuyukai Neurology Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Fulminant attack; Immunogenetic background; Multiple sclerosis; Neuromyelitis optica; Opticospinal MS

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEREDITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; IDIOPATHIC INFLAMMATORY DEMYELINATING DISORDER; IMMUNOGENETICS; INFLAMMATORY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; RELAPSE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DEMOGRAPHY; DEMYELINATING DISEASES; DISABILITY EVALUATION; DNA FINGERPRINTING; FEMALE; FOLLOW-UP STUDIES; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4744345921     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.07.003     Document Type: Article

References (45)

1. A. Siva, and O. Kantarci An introduction to the clinical spectrum of inflammatory demyelinating disorders of the central nervous system A. Siva J. Kesselring A. Thompson Frontiers in multiple sclerosis vol. II 1999 Martin Dunitz London 1 9
2. B.D. Yaul, A.G. Kermode, A.J. Thompson, T. Revesz, F. Scaravilli, and R.O. Barnard Destructive lesions in demyelinating disease J. Neurol. Neurosurg. Psychiatry 54 1991 288 292
3. C.M. Poser The epidemiology of multiple sclerosis: a general overview Ann. Neurol. 36 S2 1994 S180 S193
4. J.I. O'Riordan, H.L. Gallagher, A.J. Thompson, R.S. Howard, D.P.E. Kingsley, and E.J. Thompson Clinical, CSF, and MRI findings in Devic's neuromyelitis optica J. Neurol. Neurosurg. Psychiatry 60 1996 382 387
5. D.M. Wingerchuk, W.F. Hogancamp, P.C. O'Brien, and B.G. Weinshenker The clinical course of neuromyelitis optica (Devic's syndrome) Neurology 53 1999 1107 1114
6. T. Fukazawa, S. Kikuchi, H. Sasaki, K. Hamada, T. Hamada, and K. Miyasaka The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds J. Neurol. Sci. 158 1998 209 214
7. C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauser, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann. Neurol. 47 2000 707 717
8. J.R. Oksenberg, S.E. Baranzini, L.F. Barcellos, and S.L. Hauser Multiple sclerosis: genomic rewards J. Neuroimmunol. 113 2001 171 184
9. S. Kikuchi, T. Fukazawa, M. Niino, I. Yabe, R. Miyagishi, and T. Hamada HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands Neurology 60 2003 647 651
10. H. Shibasaki, W.I. MacDonald, and Y. Kuroiwa Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients J. Neurol. Sci. 49 1981 253 261
11. J. Kira, T. Kanai, Y. Nishimura, K. Yamasaki, S. Matsushita, and Kawano Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders Ann. Neurol. 40 1996 569 574
12. T. Fukazawa, K. Tashiro, T. Hamada, F. Moriwaka, A. Matsumoto, and K. Shima Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features Intern. Med. 31 1992 349 352
13. I. Miyazawa, K. Fujihara, and Y. Itoyama Neuromyelitis optica (Devic disease) and optic-spinal form multiple sclerosis Brain Nerve (Japanese) 53 2001 901 910
14. B.G. Weinshenker Neuromyelitis optica: what it is and what it might be Lancet 361 2003 889 890
15. F. Ikuta Problems in the pathoanatomy of multiple sclerosis. Realities of multiple sclerosis pathology on the US and Japanese cases Y. Kuroiwa Multiple sclerosis in Asia 1976 University of Tokyo Press Tokyo 143 153
16. F. Ikuta, M. Koga, S. Takeda, and Ohhama Comparison of multiple sclerosis pathology between 70 American and 75 Japanese autopsy cases Y. Kuoiwa L.T. Kurland Multiple sclerosis East and West 1982 Kyushu University Press Fukuoka 297 306
17. I. Nakashima, K. Fujihara, and Y. Itoyama Oligoclonal IgG bands in Japanese multiple sclerosis patients J. Neuroimmunol. 101 1999 205 206
18. K. Yamasaki, I. Horiuchi, M. Minohara, and Y. Kawano HLA-DPB1*0501- associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies Brain 122 1999 1689 1696
19. T. Fukazawa, S. Kikuchi, H. Sasaki, I. Yabe, R. Miyagishi, and T. Hamada Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele J. Neurol. 247 2000 175 178
20. D.A.S. Compston, H. Kellar Wood, N. Robertson, S. Sawcer, and N.W. Wood Genes and susceptibility to multiple sclerosis Acta Neurol. Scand. Suppl. 161 1995 43 51
21. T. Fukazawa, K. Yamasaki, H. Ito, S. Kikuchi, M. Minohara, and I. Horiuchi Both the HLA-DPB1 and-DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors Tissue Antigens 55 2000 199 205
22. T. Fukazawa, T. Hamada, K. Tashiro, F. Moriwaka, and T. Yanagihara Acute transverse myelopathy in multiple sclerosis J. Neurol. Sci. 100 1990 217 222
23. T. Fukazawa, K. Miyasaka, K. Tashiro, T. Hamada, F. Moriwaka, and T. Yanagihara MRI findings of multiple sclerosis with acute transverse myelopathy J. Neurol. Sci. 110 1992 27 31
24. T. Fukazawa, T. Hamada, F. Moriwaka, and K. Tashiro Acute transverse myelopathy in MS: clinical considerations Int. MS J. 1 1994 27 33
25. T. Fukazawa, S. Kikuchi, M. Niino, I. Yabe, T. Hamada, and K. Tashiro Multiphasic demyelinating disorder with acute transverse myelitis in Japanese J. Neurol. 250 2003 624 626
26. T. Misu, K. Fijihara, I. Nakashima, I. Miyazawa, N. Okita, and S. Takase Pure optic-spinal form of multiple sclerosis in Japan Brain 125 2002 2460 2468
27. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann. Neurol. 50 2001 121 127
28. T. Fukazawa, T. Hamada, S. Kikuchi, H. Sasaki, K. Tashiro, and S. Maguchi Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan J. Neurol. Neurosurg. Psychiatry 61 1996 203 212
29. I. Buyse, R. Decorte, M. Baens, H. Cuppens, G. Semana, and M.-P. Emonds Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization Tissue Antigens 41 1993 1 14
30. H. Ito, K. Yamasaki, Y. Kawano, I. Horiuchi, C. Yun, and Y. Nishimura HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese Tissue Antigens 52 1998 179 182
31. J.J. Ma, M. Nishimura, H. Mine, H. Saji, M. Ohta, and K. Saida HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis J. Neuroimmunol. 92 1998 109 112
32. T. Ono, M.R. Zambenedetti, K. Yamasaki, Y. Kawano, N. Kamikawaji, and H. Ito Molecular analysis of HLA class I (HLA-A and B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type) Tissue Antigens 52 1998 539 542
33. M. Schmied, H. Breitschopf, R. Gold, H. Zischler, G. Rothe, and H. Wekerle Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain Am. J. Pathol. 143 1993 446 452
34. T. Fukazawa, T. Yanagawa, S. Kikuchi, I. Yabe, H. Sasaki, and T. Hmada CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients J. Neurol. Sci. 171 1999 49 55
35. M. Niino, S. Kikuchi, T. Fukazawa, R. Miyagishi, I. Yabe, and K. Tashiro An examination of the Apo-1/Fas promoter MvaI polymorphism in Japanese patients with multiple BMC Neurol. 2 2002 1 5
36. J. Kira, K. Yamasaki, I. Horiuchi, Y. Ohyagi, K. Taniwaki, and Y. Kawano Changes in the clinical phenotypes of multiple sclerosis during the 50 years in Japan J. Neurol. Sci. 166 1999 53 57
37. I. Nakashima, K. Fujihara, S. Takase, and Y. Itoyama Decrease in multiple sclerosis with acute transverse myelitis in Japan Tohoku J. Exp. Med. 188 1999 89 94
38. K.M. Lee, E. Chuang, M. Griffin, R. Khattri, D.K. Hong, and W. Zhang Molecular basis of T-cell inactivation by CTLA-4 Science 282 1998 2263 2266
39. A. Ligers, N. Teleshova, T. Masterman, W.X. Huang, and J. Hillert CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun. 2 2001 145 152
40. H.F. Harbo, E.G. Celius, F. Vartdal, and A. Spurkland CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis Tissue Antigens 53 1999 106 110
41. A. Ligers, C. Xu, S. Saarinen, J. Hillert, and O. Olerup The CTLA-4 is associated with multiple sclerosis J. Neuroimmunol. 97 1999 182 190
42. T. Yanagawa, K. Gomi, E. Nakao, and S. Inada CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis J. Rheumatol. 27 2000 2740 2742
43. H.B. Rasmussen, M.A. Kelly, D.A. Francis, and J. Clausen CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese J. Neurol. Sci. 184 2001 143 147
44. A. Bitsch, and W. Bruck Differentiation of multiple sclerosis subtypes: implications for treatment CNS drugs 16 2002 405 418
45. R.N. Mandler, W. Ahmed, and J.E. Dencoff Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine Neurology 51 1998 1219 1220